Future Heath is a platform dedicated to the provision of investment services and early-stage capital for health and wellness related investments.
Through its discretionary portfolio, Future Health has made investments into a number of successful growth companies including Vaccitech, the Oxford University vaccine platform behind the AZ COVID jab (recently listed on NASDAQ), and Viome, the world’s lead gut science company which has recently raised funding at a value of 850 million USD pre planned IPO.
MyDoc is Asia’s leading telemedicine service company. MyDoc’s fully integrated online-to-offline platform streamlines all aspects of primary healthcare into one easy-to-use solution connecting patients to doctors, pharmacies, diagnostic laboratories, clinical-grade health trackers, Fortune 500 and SME employers, and insurers.Request Access
CanVirex is a next generation immuno-therapeutics company, developing a recombinant viral vector platform for cancer immunotherapy and a second- generation vaccination against COVID-19. The company is currently raising CHF 10m in its current funding round.Request Access
World-leading AgriScience company established as the commercialisation arm of the renowned Roslin Institute and University of Edinburgh’s Royal (Dick) School of Veterinary Studies. Currently raising Series B funding round.Request Access
Protenga is a global leader in the transformation of biomass into green animal feed through the implementation of Black Soldier Fly bioconversionRequest Access